Form 8-K - Current report:
SEC Accession No. 0001193125-25-080277
Filing Date
2025-04-14
Accepted
2025-04-14 17:03:11
Documents
13
Period of Report
2025-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d894534d8k.htm   iXBRL 8-K 27576
  Complete submission text file 0001193125-25-080277.txt   146653

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cue-20250410.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20250410_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20250410_pre.xml EX-101.PRE 10822
16 EXTRACTED XBRL INSTANCE DOCUMENT d894534d8k_htm.xml XML 3525
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 25836651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)